Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.
Identifieur interne : 002353 ( Main/Exploration ); précédent : 002352; suivant : 002354Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.
Auteurs : Ilona Goldfarb [États-Unis] ; Britta Panda ; Blair Wylie ; Laura RileySource :
- American journal of obstetrics and gynecology [ 1097-6868 ] ; 2011.
Descripteurs français
- KwdFr :
- Acceptation des soins par le patient (), Antiviraux (usage thérapeutique), Complications de la grossesse et maladies infectieuses (), Complications de la grossesse et maladies infectieuses (traitement médicamenteux), Connaissances, attitudes et pratiques en santé, Femelle, Femmes enceintes (psychologie), Grippe humaine (), Grippe humaine (traitement médicamenteux), Grippe humaine (épidémiologie), Grossesse, Humains, Massachusetts (épidémiologie), Oséltamivir (usage thérapeutique), Pandémies, Refus de traitement (), Saisons, Sous-type H1N1 du virus de la grippe A (immunologie), Sécurité, Vaccination (), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (effets indésirables).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- effets indésirables : Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A.
- psychologie : Femmes enceintes.
- traitement médicamenteux : Complications de la grossesse et maladies infectieuses, Grippe humaine.
- usage thérapeutique : Antiviraux, Oséltamivir.
- épidémiologie : Grippe humaine, Massachusetts.
- Acceptation des soins par le patient, Complications de la grossesse et maladies infectieuses, Connaissances, attitudes et pratiques en santé, Femelle, Grippe humaine, Grossesse, Humains, Pandémies, Refus de traitement, Saisons, Sécurité, Vaccination.
English descriptors
- KwdEn :
- Antiviral Agents (therapeutic use), Female, Health Knowledge, Attitudes, Practice, Humans, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (adverse effects), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Massachusetts (epidemiology), Oseltamivir (therapeutic use), Pandemics, Patient Acceptance of Health Care (statistics & numerical data), Pregnancy, Pregnancy Complications, Infectious (drug therapy), Pregnancy Complications, Infectious (prevention & control), Pregnant Women (psychology), Safety, Seasons, Treatment Refusal (statistics & numerical data), Vaccination (statistics & numerical data).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , adverse effects : Influenza Vaccines.
- chemical , therapeutic use : Antiviral Agents, Oseltamivir.
- drug therapy : Influenza, Human, Pregnancy Complications, Infectious.
- epidemiology : Influenza, Human, Massachusetts.
- immunology : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- psychology : Pregnant Women.
- statistics & numerical data : Patient Acceptance of Health Care, Treatment Refusal, Vaccination.
- Female, Health Knowledge, Attitudes, Practice, Humans, Pandemics, Pregnancy, Safety, Seasons.
Abstract
The goals of this study were to define the uptake of H1N1 and seasonal influenza vaccination during pregnancy among women delivering during the 2009 H1N1 pandemic and explore barriers to vaccination. All postpartum women at the Massachusetts General Hospital from January 2010 through March 2010 were invited to complete an anonymous questionnaire about demographics, vaccination status, and attitudes about vaccination during pregnancy. Among 370 participants (53% response rate), 81% accepted both the H1N1 and seasonal influenza vaccines during pregnancy. Patients who declined one or both vaccines cited concerns over safety as a major deterrent. Of the 36% of participants who reported having flu-like symptoms during this pregnancy only 8.6% took oseltamivir. While a high vaccination rate was identified in this study, further education is needed to reassure patients regarding vaccine safety. Education for providers and patients emphasizing the benefits of early treatment of pregnant women with flu-like symptoms should be a priority.
DOI: 10.1016/j.ajog.2011.01.007
PubMed: 21345408
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001094
- to stream PubMed, to step Curation: 001094
- to stream PubMed, to step Checkpoint: 000D99
- to stream Ncbi, to step Merge: 000F66
- to stream Ncbi, to step Curation: 000F66
- to stream Ncbi, to step Checkpoint: 000F66
- to stream Main, to step Merge: 002428
- to stream Main, to step Curation: 002353
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.</title><author><name sortKey="Goldfarb, Ilona" sort="Goldfarb, Ilona" uniqKey="Goldfarb I" first="Ilona" last="Goldfarb">Ilona Goldfarb</name><affiliation wicri:level="2"><nlm:affiliation>Massachusetts General Hospital Vincent Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA, USA. igoldfarb@partners.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Massachusetts General Hospital Vincent Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Panda, Britta" sort="Panda, Britta" uniqKey="Panda B" first="Britta" last="Panda">Britta Panda</name></author><author><name sortKey="Wylie, Blair" sort="Wylie, Blair" uniqKey="Wylie B" first="Blair" last="Wylie">Blair Wylie</name></author><author><name sortKey="Riley, Laura" sort="Riley, Laura" uniqKey="Riley L" first="Laura" last="Riley">Laura Riley</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21345408</idno><idno type="pmid">21345408</idno><idno type="doi">10.1016/j.ajog.2011.01.007</idno><idno type="wicri:Area/PubMed/Corpus">001094</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001094</idno><idno type="wicri:Area/PubMed/Curation">001094</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001094</idno><idno type="wicri:Area/PubMed/Checkpoint">000D99</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D99</idno><idno type="wicri:Area/Ncbi/Merge">000F66</idno><idno type="wicri:Area/Ncbi/Curation">000F66</idno><idno type="wicri:Area/Ncbi/Checkpoint">000F66</idno><idno type="wicri:Area/Main/Merge">002428</idno><idno type="wicri:Area/Main/Curation">002353</idno><idno type="wicri:Area/Main/Exploration">002353</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.</title><author><name sortKey="Goldfarb, Ilona" sort="Goldfarb, Ilona" uniqKey="Goldfarb I" first="Ilona" last="Goldfarb">Ilona Goldfarb</name><affiliation wicri:level="2"><nlm:affiliation>Massachusetts General Hospital Vincent Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA, USA. igoldfarb@partners.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Massachusetts General Hospital Vincent Department of Obstetrics and Gynecology, Harvard Medical School, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Panda, Britta" sort="Panda, Britta" uniqKey="Panda B" first="Britta" last="Panda">Britta Panda</name></author><author><name sortKey="Wylie, Blair" sort="Wylie, Blair" uniqKey="Wylie B" first="Blair" last="Wylie">Blair Wylie</name></author><author><name sortKey="Riley, Laura" sort="Riley, Laura" uniqKey="Riley L" first="Laura" last="Riley">Laura Riley</name></author></analytic><series><title level="j">American journal of obstetrics and gynecology</title><idno type="eISSN">1097-6868</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza, Human (drug therapy)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Massachusetts (epidemiology)</term><term>Oseltamivir (therapeutic use)</term><term>Pandemics</term><term>Patient Acceptance of Health Care (statistics & numerical data)</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (drug therapy)</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnant Women (psychology)</term><term>Safety</term><term>Seasons</term><term>Treatment Refusal (statistics & numerical data)</term><term>Vaccination (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par le patient ()</term><term>Antiviraux (usage thérapeutique)</term><term>Complications de la grossesse et maladies infectieuses ()</term><term>Complications de la grossesse et maladies infectieuses (traitement médicamenteux)</term><term>Connaissances, attitudes et pratiques en santé</term><term>Femelle</term><term>Femmes enceintes (psychologie)</term><term>Grippe humaine ()</term><term>Grippe humaine (traitement médicamenteux)</term><term>Grippe humaine (épidémiologie)</term><term>Grossesse</term><term>Humains</term><term>Massachusetts (épidémiologie)</term><term>Oséltamivir (usage thérapeutique)</term><term>Pandémies</term><term>Refus de traitement ()</term><term>Saisons</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sécurité</term><term>Vaccination ()</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (effets indésirables)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term><term>Oseltamivir</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Massachusetts</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Femmes enceintes</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Pregnant Women</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term><term>Treatment Refusal</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Oséltamivir</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Massachusetts</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Pandemics</term><term>Pregnancy</term><term>Safety</term><term>Seasons</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acceptation des soins par le patient</term><term>Complications de la grossesse et maladies infectieuses</term><term>Connaissances, attitudes et pratiques en santé</term><term>Femelle</term><term>Grippe humaine</term><term>Grossesse</term><term>Humains</term><term>Pandémies</term><term>Refus de traitement</term><term>Saisons</term><term>Sécurité</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The goals of this study were to define the uptake of H1N1 and seasonal influenza vaccination during pregnancy among women delivering during the 2009 H1N1 pandemic and explore barriers to vaccination. All postpartum women at the Massachusetts General Hospital from January 2010 through March 2010 were invited to complete an anonymous questionnaire about demographics, vaccination status, and attitudes about vaccination during pregnancy. Among 370 participants (53% response rate), 81% accepted both the H1N1 and seasonal influenza vaccines during pregnancy. Patients who declined one or both vaccines cited concerns over safety as a major deterrent. Of the 36% of participants who reported having flu-like symptoms during this pregnancy only 8.6% took oseltamivir. While a high vaccination rate was identified in this study, further education is needed to reassure patients regarding vaccine safety. Education for providers and patients emphasizing the benefits of early treatment of pregnant women with flu-like symptoms should be a priority.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><noCountry><name sortKey="Panda, Britta" sort="Panda, Britta" uniqKey="Panda B" first="Britta" last="Panda">Britta Panda</name><name sortKey="Riley, Laura" sort="Riley, Laura" uniqKey="Riley L" first="Laura" last="Riley">Laura Riley</name><name sortKey="Wylie, Blair" sort="Wylie, Blair" uniqKey="Wylie B" first="Blair" last="Wylie">Blair Wylie</name></noCountry><country name="États-Unis"><region name="Massachusetts"><name sortKey="Goldfarb, Ilona" sort="Goldfarb, Ilona" uniqKey="Goldfarb I" first="Ilona" last="Goldfarb">Ilona Goldfarb</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002353 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002353 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21345408
|texte= Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21345408" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |